Mistaken attachments cause cancer-promoting chromosome distribution errors

April 30, 2001

Some chromosomes are not properly distributed to dividing cells because both of the two newly forming cells try to pull the chromosome their way, a new study says. This appears to be a major source of distribution errors -- errors that often lead to cancer. Dividing cells first duplicate each of their chromosomes, then use a diamond-shaped apparatus called the spindle to pull one copy of each chromosome into each of the two new cells. Edward Salmon (University of North Carolina at Chapel Hill) and colleagues report in the April 30 issue of The Journal of Cell Biology that the most frequent errors in this process resulted from the attachment of one copy of the chromosome to both ends of the spindle. When all the other chromosomes moved into the two new cells, the mistakenly attached chromosome was left behind in the middle of the dividing cell.

Salmon believes that the problem arises because kinetochores, the areas of chromosomes that attach to the spindle, must satisfy conflicting requirements. Kinetochores must be big enough to ensure attachment to at least one side of the spindle, but small enough such that attachment to both sides of the spindle is unlikely. Sometimes this trade-off does not work out.

The cell has a special surveillance mechanism for detecting errors in chromosome attachment. If the cell detects such errors it pauses to correct them before dividing. This system is good at detecting chromosomes that are not attached to the spindle, or chromosome pairs where both members of the pair are attached to the same side of the spindle. The surveillance system probably detects a lack of pulling or tension at the kinetochore, but unfortunately the kinetochores that Salmon studied were being pulled from both sides. Thus this type of error is not detected by the cell, and can easily lead to mistakes in the number of chromosomes distributed to each cell. Such mistakes are commonly a trigger for cancer.
-end-
Contact: Edward Salmon, University of North Carolina at Chapel Hill, 919 962-2265, tsalmon@email.unc.edu

Journal of Experimental Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.